Puma Biotechnology Inc (PBYI)
4.095
-0.32
(-7.14%)
USD |
NASDAQ |
May 17, 16:00
4.20
+0.10
(+2.56%)
Pre-Market: 20:00
Puma Biotechnology Research and Development Expense (Quarterly): 13.59M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 13.59M |
December 31, 2023 | 12.87M |
September 30, 2023 | 11.45M |
June 30, 2023 | 13.36M |
March 31, 2023 | 12.71M |
December 31, 2022 | 13.78M |
September 30, 2022 | 11.25M |
June 30, 2022 | 11.97M |
March 31, 2022 | 15.24M |
December 31, 2021 | 14.17M |
September 30, 2021 | 18.84M |
June 30, 2021 | 18.64M |
March 31, 2021 | 20.23M |
December 31, 2020 | 24.16M |
September 30, 2020 | 23.34M |
June 30, 2020 | 24.69M |
March 31, 2020 | 25.46M |
December 31, 2019 | 30.24M |
September 30, 2019 | 30.03M |
June 30, 2019 | 36.86M |
March 31, 2019 | 35.73M |
December 31, 2018 | 38.32M |
September 30, 2018 | 36.36M |
June 30, 2018 | 43.24M |
March 31, 2018 | 46.92M |
Date | Value |
---|---|
December 31, 2017 | 50.25M |
September 30, 2017 | 49.50M |
June 30, 2017 | 53.25M |
March 31, 2017 | 54.80M |
December 31, 2016 | 56.40M |
September 30, 2016 | 51.98M |
June 30, 2016 | 54.22M |
March 31, 2016 | 60.21M |
December 31, 2015 | 52.44M |
September 30, 2015 | 51.92M |
June 30, 2015 | 59.38M |
March 31, 2015 | 44.73M |
December 31, 2014 | 39.53M |
September 30, 2014 | 32.09M |
June 30, 2014 | 35.00M |
March 31, 2014 | 16.29M |
December 31, 2013 | 13.01M |
September 30, 2013 | 12.07M |
June 30, 2013 | 10.44M |
March 31, 2013 | 9.532M |
December 31, 2012 | 8.282M |
September 30, 2012 | 17.78M |
June 30, 2012 | 13.01M |
March 31, 2012 | 10.57M |
December 31, 2011 | 0.826M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
11.25M
Minimum
Sep 2022
36.86M
Maximum
Jun 2019
19.14M
Average
16.94M
Median
Research and Development Expense (Quarterly) Benchmarks
ADMA Biologics Inc | 0.45M |
Pfizer Inc | 2.493B |
United Therapeutics Corp | 104.10M |
Vanda Pharmaceuticals Inc | 21.15M |
Sarepta Therapeutics Inc | 200.40M |